Category Archives: Regulatory Burden

National Science Board meets to discuss policy issues

On November 7-8, the National Science Board (NSB) met at National Science Foundation (NSF) headquarters in Arlington, Virginia, to discuss a long slate of science policy issues. Many topics were raised during the open sessions of the meeting, including an update on the NSF strategic plan, discussions of a new pilot program pertaining to NSF… Read More »

National academies workshop on animal models for microbiome research

The National Academy of Sciences Institute for Laboratory Animal Research (ILAR) Roundtable will host a workshop entitled, “Animal Models for Microbiome Research: Advancing Basic and Translational Science” on December 19–20. The workshop agenda includes discussions on the standardization and biological variability in gnotobiotic organisms, the translatability of preclinical studies to humans, alternative models for microbiome research, and… Read More »

HHS advisory committee addresses institutional review board rules

The fall meeting of the Secretary’s Advisory Committee on Human Research Protections (SACHRP) on October 25–26 focused in large part on clarifying new rules affecting institutional review boards (IRB). The committee advises the Secretary of Health and Human Services on human subjects research matters and offers recommendations to researchers and institutions conducting studies with human… Read More »

NIH seeks input on inclusion of preprints in grant applications and reports

On October 6, the National Institutes of Health (NIH) released a Request for Information (RFI) seeking input on the inclusion of interim research products and preprints in grant applications and reports as well as known standards for reporting such products. Specifically, NIH asks the research community to provide insights about existing interim research products and… Read More »

New rules on registering and reporting clinical trials

The Department of Health and Human Services (HHS) issued new rules on announcing clinical trials and reporting their results. On September 16, HHS released the Final Rule on clinical trials registration and summary results information submission on the website. The Final Rule mirrors the Notice of Proposed Rulemaking (NPRM) published in November 2014. At… Read More »

FASEB supports NSF’s strategic plan

As the National Science Foundation (NSF) prepares to draft its next four-year strategic plan, the Federation of American Societies for Experimental Biology (FASEB) urged the agency to continue its support for fundamental, investigator-initiated research and its efforts to streamline and harmonize operations at the Foundation. Both of these topics are major themes of the current… Read More »

FASEB supports Senate follow-up to America COMPETES Act

The Federation of American Societies for Experimental Biology (FASEB) voiced its support for legislation approved by the Senate Committee on Commerce, Science, and Transportation on June 29 entitled the American Innovation and Competitiveness Act (AICA). The bill, spearheaded by Senators Cory Gardner (R-CO) and Gary Peters (D-MI) as the Senate’s effort to follow-up the America COMPETES… Read More »